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Tissue engineering is an approach to the regeneration of tissues that uses a combination of cell sources,
signaling factors and scaffolds. Among these three components, signaling factors for bone regeneration
have not yet been established, and it is necessary to better understand osteoblast progenitors as a target
cells. Several lines of evidence have revealed that, during bone formation, mesenchymal cells are
speciﬁed and differentiate into osteoblasts through several stages of precursors. The osteoblast lineage is
deﬁned by the expression of stage-speciﬁc transcription factors. The speciﬁcation and differentiation are
organized by a variety of signaling pathways including hedgehog (Hh), Wnt, Notch, bone morphogenetic
protein (BMP) and transforming growth factor-beta (TGFb). In this review we integrate the known
functions of these signaling pathways and discuss future tasks to gain a better understanding of the
signaling network in osteogenesis for tissue engineering.
© 2014 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. All rights
reserved.1. Introduction
Mammalian bones have three distinct origins; the paraxial
mesoderm, the lateral plate mesoderm, and the neural crest. The
paraxial mesoderm gives rise to the axial skeleton. The lateral plate
mesoderm gives rise to the appendicular skeleton and the neural
crest gives rise to cranial skeleton. There are two modes of bone
formation; intramembranous and endochondral bone formation. In
intramembranous ossiﬁcation, mesenchymal cells condense and
directly differentiate into osteoblasts to deposit bone matrix,
whereas in endochondral ossiﬁcation, after the condensation of
mesenchymal cells, a cartilage mold is formed and subsequently
the mold is replaced by bone tissue. Bones derived from the para-
xial mesoderm and lateral plate mesoderm are formed mainly
through the endochondral process. In the initial phase of theer for Regenerative Medicine
ornia, 1425 San Pablo St, Los
þ1 323 442 8024.
ojo).
se Society for Regenerative
tive Medicine. Production and hosprocess, two distinct cell populations arise after the condensation
of mesenchymal cells: cartilage-forming chondrocytes and peri-
chondrial cells [1].
SRY box-containing gene 9 (Sox9) has been shown to be
essential for the mesenchymal condensations and subsequent
cartilage formation [2,3]. Perichondrial cells constitute the peri-
chondrium, a thin layer of ﬁbroblastic cells surrounding the carti-
lage mold. During the process, a population of the perichondrial
cells is speciﬁed into the osteoblast lineage; they differentiate into
osteoblasts through several stages of precursors, contributing to
the formation of the bone collar, a predecessor of cortical bones and
being a source of primary spongiosa [1,4].
Runt-related transcription factor 2 (Runx2) and osterix (Osx) are
two essential transcription factors for osteoblast differentiation.
Genetic studies have shown that Osx is downstream of Runx2
[5e7]. The sequential osteoblast differentiation is characterized by
the expression of stage-speciﬁc transcription factors: Sox9-positive
mesenchymal cells, called osteo-chondroprogenitors, give rise to
Runx2-positive osteoblast precursors. The precursors differentiate
into Osx-positive osteoblast precursors, followed by their matura-
tion to bone forming osteoblasts [8,9]. A variety of signaling path-
ways have been shown to function at speciﬁc and/or multipleting by Elsevier B.V. All rights reserved.
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Wnt, BMP, and Notch pathways have been shown to play pivotal
roles. Here, we review these signaling pathways and discuss how
these pathways form a network to regulate ossiﬁcation.
2. Signaling pathways in the osteoblast lineage
2.1. Hh signaling
Mammals have three homologs of drosophila hedgehog: Sonic
hedgehog (Shh), Indian hedgehog (Ihh), and Desert hedgehog
(Dhh). Among them, Ihh has been shown to be essential for
endochondral ossiﬁcation. Ihh is expressed in prehypertrophic
chondrocytes and secreted to specify a certain cell population in the
perichondrium into osteoblast precursors [10,11]. In Col2a1-
Gal4;UAS-Ihh and Col2a1-Cre;Patched1/ (Ptch1; a Hh ligand re-
ceptor functioning as a repressor of the signaling) mouse embryos,
bone collar formation is enhanced by the mesenchymal cell-
speciﬁc gain-of-function of Hh signaling [11,12].
Regarding the loss of function, bone collar is absent following
Ihh ablation and following the chondrocyte- and perichondrium-
speciﬁc ablation of Smoothened (Smo; a receptor of Hh ligand
functioning as a transducer of Hh activation) using a Col2a1-Cre
driver [10,11]. Importantly, neither Runx2 expression nor bone
collar formation has been shown in these mutants. These data
suggest that Ihh acts as a switch to initiate a program of osteoblast
lineage in the Runx2-negative mesenchymal cell state and generate
the Runx2-positive osteoblast precursors. In addition, in the
absence of Ihh signaling, cells in the perichondrium seem to adopt a
chondrocyte fate, as following two lines of evidence; by the layer of
immature chondrocytes that surround the hypertrophic chon-
drocytes in Ihh/ mice [10], and by the existence of ectopic
chondrocytes in Smo/ perichondrial cells in chimeric mice [11].
The zinc ﬁnger transcription factors Gli1, Gli2 and Gli3 are
thought to mediate transcriptional responses to Hh input. Gli1 is a
transcriptional activator. Gli2 is suggested to function primarily as a
transcriptional activator, and Gli3 as a transcriptional repressor
[13]. Which Gli proteins play important roles in the Ihh-mediated
function to specify progenitors into an osteoblast lineage? Impair-
ment of the early osteoblast differentiation in Ihh/ embryos is
partially rescued by the disruption of Gli3 [14,15], whereas it is
completely rescued in Ihh/;Gli3/;C2DNGli2 embryos, in which
DNGli2 (an N-terminally truncated form of Gli2, as a constitutively
active form of Gli2) is exogenously expressed in Col2a1-positive
cells [16].
In addition, we recently reported that, in addition to Gli2 and
Gli3, Gli1 is involved in the Ihh signaling-mediated speciﬁcation of
the osteoblast lineage [17]. Gli1 overexpression induces osteoblast
marker genes in vitro and Gli1/ shows impaired bone collar for-
mation. Moreover, Gli1/;Gli2/ mice show more severe pheno-
types of impaired bone formation than the single knock-out mice
[17]. These data suggest that all Gli members function coopera-
tively in osteogenesis. A question that has not been answered is
whether all members of the Gli family function independently of
each other or act collectively at a particular stage in this context.
In despite of the signiﬁcance of the Ihh function in embryonic
skeletal development, limited number of studies addressed the
roles in the postnatal skeleton. Ohba et al. reported that adult
Ptch1þ/ mice show high bone mass due primarily to enhanced
osteoblast differentiation [18]. The mature osteoblast-speciﬁc
ablation of Ptch1 using osteocalcin-Cre driver leads to increases in
both osteoblastogenesis and osteoclastogenesis, resulting in
decreased bone mass and osteopenia [19]. Maeda et al. reported
that the chondrocyte-speciﬁc ablation of Ihh in newbornmice using
Col2a1-CreERmice results in impaired growth plate formation, andin the loss of trabecular bone continuously in older mice [20]. In
addition, administration of a Hh inhibitor in young mice leads to a
decrease in bonemass and the disruption of bone structure through
suppressed osteoblast differentiation [18,21].
Regarding the Gli family, the Osx-positive cell-speciﬁc activation
of Gli2 using Osx-GFP::Cre driver, which is BAC transgenic mouse
line expressing a GFP::Cre fusion protein under the regulation of
the Osx promoter, exhibits severe osteopenia due to a marked
decrease in osteoblast number and function, although bone
resorption is not affected [22]. Taken together, the above ﬁndings
indicate that Hh signaling is necessary for proper bone formation.
However, the excessive activation of Hh signaling is likely to lead to
osteopenia through enhanced osteoclastogenesis and/or indirect
actions of osteoclastogenesis.
2.2. Wnt signaling
A number of the Wnt family proteins are expressed in skeletal
tissue and regulate endochondral ossiﬁcation through canonical
and non-canonical Wnt signaling pathways [23]. In the canonical
Wnt pathway [24,25], Wnts bind to Frizzled receptors and the low-
density lipoprotein receptor-related protein 5 or 6 (LRP5/6) in
vertebrates [26e28], which leads to stabilization of beta-catenin (b-
catenin) and activation of the transcription of target genes via
lymphoid enhancer binding factor-1 (Lef-1) and T cell factors (Tcf1,
3, 4).
The amplitude of the signaling is ﬁne-tuned in part via negative
feedback mechanisms that involve the secreted molecule Dickkopf
1 (Dkk1) [29], a direct transcriptional target of canonical Wnt
signaling [30,31]. Dkk1 antagonizes the pathway by interfering
with the interaction between LRP5/6 and Wnt [32e34]. Non-
canonical Wnt pathways include a planar cell polarity pathway, a
Ca2þ/protein kinase A pathway, and a protein kinase C-dependent
pathway [35].
Genetic studies indicate that a certain threshold level of theWnt
signaling is required for multiple stages of osteoblast lineages. The
limb bud mesenchyme-speciﬁc ablation of Ctnnb1 (which encodes
b-catenin) using Prx1-Cre driver [36] and a mesenchymal progen-
itor cell-speciﬁc ablation of Ctnnb1 using Dermo1-Cre driver [37,38]
result in greatly diminished osteoblast marker expressions, such as
those of collagen I, Osx, and osteocalcin, whereas the initiation of the
osteoblast differentiation and Runx2 expression are not affected in
these mice. These data indicate that canonical Wnt signaling is
required for osteoblast precursors to differentiate into an Osx-
positive stage. In mice with the Osx-positive cell-speciﬁc ablation
of Ctnnb1 using the Osx-GFP::Cre driver, cells fail to progress to
mature osteoblast stages characterized by high osteocalcin
expression, although Runx2 and Osx were expressed [9]. Stabiliza-
tion of b-catenin in Osx-positive cells using the Osx1-GFP::Cre re-
sults in robust increase of the proliferation of osteoblast precursors,
but the attenuation of their terminal differentiation to osteocalcin-
positive osteoblasts [9]. These ﬁndings indicate that canonical Wnt
signaling needs to be kept within a physiological range in order to
positively promote osteoblastogenesis. In addition, when Ctnnb1 is
removed using the Dermo1-Cre, Prx1-Cre, Col2a1-Cre or Osx1-
GFP::Cre drivers, ectopic chondrocytes are observed in the peri-
chondrium at the expense of osteoblast differentiation during
endochondral ossiﬁcation [9,36,37]. Notably, perichondrial cells in
mice with the Osx-positive cell-speciﬁc ablation of Ctnnb1 express
Ptch1, a readout of Hh signaling activation, indicating that Hh
signaling is activated in the cells. These data raise the possibility
that osteoblast precursors still have the bipotential ability to
differentiate into not only osteoblasts but also chondrocytes even
after they have already committed to an osteoblast lineage by Hh
signaling.
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formation is supported by genetic evidence. In humans, LRP-5 loss-
of function mutations are linked with the osteoporosis-
pseudoglioma syndrome [39], while the gain-of function muta-
tions are linked with a familial high bone density phenotype [40].
Similarly, in mice, Lrp-5/ [41] and Wnt10b/ mice [42] exhibit
reduced bone mass. Reduction of Lrp-6 in Lrp5/mice is shown to
further reduce bone mass [43]. Conversely, mice lacking the
secreted Frizzled related protein which is a Wnt antagonist,
develop more bone mass in the postnatal life [44]. As for non-
canonical pathways, G protein-coupled phosphatidylinositol and
PKCD activation are involved in the Wnt-mediated osteoblast dif-
ferentiation [45]. Non-canonical Wnt5a induces osteoblast differ-
entiation in vitro, while Wnt5aþ/ shows bone loss in adult mice
[46].
2.3. Notch signaling
Notch signaling functions in the communication between
neighboring cells and is involved in the cell fate determination.
Notch receptors (Notch1-4 in mammals) are single-pass trans-
membrane proteins which are composed of functional extracellular
(NECD), transmembrane (TM) and intracellular (NICD) domains.
Upon Notch ligands, such as Jagged1, 2 and Delta-like 1, 3, 4 in
mammals bound to the Notch receptors, the receptors undergo
proteolytic cleavage, resulting in released of NICD from the plasma
membrane and translocated into the nucleus [47]. In the nucleus,
NICD interacts with a transcription factor of the CSL family (RBP-Jk/
CBF-1 in mammals) to activate the transcription of target genes,
including those of the Hes/Hey family, which are transcription re-
pressors containing a conserved basic helix-loop-helix (bHLH)
domain [48]. A functional g-secretase complex containing either
presenilin 1 (PS1) or 2 (PS2) as the catalytic subunit [49e51] is
required for the intramembrane cleavage and release of the NICD.
Notch signaling plays important roles in bone formation; how-
ever, genetic studies have yielded somewhat controversial results.
Regarding gain of function, NICD transgenic mice driven by the 2.3-
kb type I collagen promoter exhibit increased bone volume with
growth retardation [52]. In contrast, overexpression of NICD driven
by the 3.6-kb type I collagen promoter leads a decrease in bone
volume through a decrease in osteoblast number [53]. Regarding
loss of function, the limb bud mesenchyme-speciﬁc ablation of PS1
and PS2 or Notch1 and Notch2 using Prx1-Cre driver do not overtly
affect the skeletal morphogenesis in the embryo, but markedly
enhance trabecular bone mass in adolescent mice [54]. Notably, the
number of mesenchymal progenitors is decreased in the bone
marrow of the mice with high bone mass, supporting a model in
which Notch signaling normally suppresses osteoblast differentia-
tion from progenitor cells. As a result, these mice develop severe
osteopenia as they aged. The osteoblast-speciﬁc ablation of PS1 and
PS2 using Col1a1-Cre driver is associated with age-related osteo-
porosis, which in turn results from increased osteoblast-dependent
osteoclastic activity due to decreased osteoprotegerin mRNA
expression [52]. Taken together with several line of evidence in the
molecular study [51e54], Notch signaling is suggested to function
to maintain a pool of mesenchymal progenitors. Bone formation
and bone homeostasis controlled by Notch signaling are possibly
modulated by other signaling factors, including BMP, Wnt, Runx2
and Osx.
2.4. TGF- b/BMP signaling
The transforming growth factor-beta (TGF-b) superfamily is a
large and diverse group of structurally related secreted growth
factors [55,56]. The TGF-b superfamily members bind as dimers toreceptor complexes consisting of heterotetrameric combinations of
types I and II serineethreonine kinase receptors. Based on the
structural characteristics and on the signal transduction pathways
that they activate, the members of this superfamily can be sub-
divided into the TGF-b class and the BMP class.
Upon a ligand binds to the receptor complex, the type II receptor
phosphorylates the type I receptor within a glycine/serine-rich (GS)
domain, which subsequently activates receptor Smads (R-Smads;
Smads 1, 2, 3, 5, and 8). R-Smads then recruit the common partner
Smad (Co-Smad; Smad4) and form complex, followed by entering
the nucleus. The complex binds to the regulatory elements of target
genes through interaction with other transcription factors [57,58].
Ligands of the BMP subclass bind to the type I receptors ALK2, ALK3
(BMPRIA), and ALK6 (BMPRIB), and activate Smads 1, 5, and 8,
whereas ligands of the TGF-b subclass bind to receptor complexes
containing the type I receptors ALK4, ALK5 (TGF-b RI), and ALK7,
and activate Smads 2 and 3. These distinctions, however, are not
always exact.
Regarding the expression patterns of BMP signaling components
in skeletal tissues, BMP2, 3, 4 and 7 are reported to be expressed in
the perichondrium [59e62], and BMP2 and 6 are mainly expressed
in hypertrophic chondrocytes in growth plate [63]. The type I BMP
receptors are also reported to have characteristic expression pat-
terns in the growth plate. ALK3 is highly expressed in columnar and
hypertrophic chondrocytes and perichondrial cells. ALK2 is
expressed primarily in round and columnar chondrocytes, while
ALK6 expression is observed throughout the growth plate,
including the developing articular surface and in the perichon-
drium [60,64e66]. The type II BMP receptor is also expressed
throughout the growth plate [60,64e66]. Thus, as is the case with
the ligands, essentially every region of the growth plate expresses
at least one type I BMP receptor.
BMPs derive their name from their potent ability to induce
ectopic bone formationwhen subcutaneously implanted in rodents
[67]. A number of studies indicate that BMPs have positive impact
on the osteoblast differentiation, whereas Noggin, a BMP antago-
nist, inhibits osteoblast differentiation [68]. Further, a heterozygous
gain-of function mutation in the gene encoding ALK2 is identiﬁed
as a clinical feature of ﬁbrodysplasia ossiﬁcans progressiva (FOP;
MIM #135100) which is an autosomal dominant disorder man-
ifested as skeletal malformations and progressive extraskeletal
ossification [69].
Despite these lines of evidence, our understanding of the role of
BMPs through genetic studies has been hampered for mainly two
reasons. First, as alreadymentioned, BMP familymembers are often
expressed in overlapping tissues and may play redundant roles.
Second, BMP signaling plays critical roles in cartilage development,
so that disruption of the pathway in the skeleton often leads to
profound early defects that preclude a precise assessment of oste-
oblast development [70]. In mice with the limb bud mesenchyme-
speciﬁc ablation of Bmp2 and Bmp4 using Prx1-Cre driver, normal
bone collar formation is observed in the fetal stage, but bone
marrow formation and trabecular bone formation are delayed at
birth [71]. Bmp2þ/; Bmp6/ mice exhibit a reduction in the
trabecular bone volumewith impaired bone formation in both fetal
and adult stages [72].
On the other hand, overexpression of Noggin driven by the
Col1a1 promoter in mice shows increased bone volume with a
decreased of both bone formation rate and osteoclast number [73].
In addition, a study of the osteoblast-speciﬁc ablation of Bmpr1a
using osteocalcin2-Cre driver shows that the response of the oste-
oblasts is age-dependent: bone volume is decreased in young mice
but increased in old mice [74]. An osteoblast-speciﬁc ablation of
Bmpr1a in adult mice using Col1a1-CreER shows increased bone
mass [75]. These data suggest that BMP signaling may not directly
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bone homeostasis after birth.
TGF-bs 1-3, ALK5 and TGF-b RII are expressed in the perichon-
drium [76,77]. Mice with the mesenchymal precursor cell-speciﬁc
ablation of ALK5 using Dermo1-Cre driver have an abnormally
thin perichondrial cell layer and reduced proliferation and differ-
entiation of osteoblasts [78]. In mice with the limb bud
mesenchyme-speciﬁc ablation of Tgfbr2 using Prx1-Cre driver, the
length of the long bones is short due primarily to a decrease in
chondrocyte proliferation and the joints are fused [79]. In addition,
Yi Tang et al. suggest a model in which active TGF-b1 released
during bone resorption coordinates bone formation by inducing the
migration of bone mesenchymal stem cells in bone marrow [80].
These data suggest that the signaling plays important roles in the
patterning, proliferation and migration of cells in the skeletal tis-
sues including osteoblast precursors, but indirectly regulates
osteoblast differentiation.
2.5. Signaling networks among Hh, Wnt and BMP signaling
As described above, Hh, Wnt and BMP signaling play important
roles in the osteoblast lineage. In this context, which signaling
pathway initiates the differentiation cascade and how do these
pathways interact with each other? Although several groups have
tried to answer these questions, the signaling networks are still not
fully revealed. Asmentioned earlier, Hh signaling appears to initiate
the osteoblast program by specifying Runx2-negative mesen-
chymal cells into Runx2-positive osteoblast precursors. However,
Hh-mediated Runx2 induction is unlikely to be sufﬁcient for this Hh
function, given that the recovery of Runx2 expression in skeletal
cells does not restore bone formation in Ihh/ embryos [81]. This
ﬁnding suggests that additional factors besides Runx2 mediate the
functions of Ihh signaling in the initiation of the osteoblast
program.
Regarding the interaction of Hh and Wnt signaling, it has been
demonstrated that the nuclear localization of b-catenin (which is a
readout of canonical Wnt signaling activation) and the expression
of target genes for the Wnt canonical pathway are abolished in the
perichondrium in Ihh/ embryos [37,38]. In contrast, the osteo-
blast differentiation and bone collar formation are normal in mice
with Osx-positive cell-speciﬁc ablation of Smo using Osx1-GFP::Cre
driver [9]. These data suggest that Wnt/b-catenin signaling acts
downstream of Hh signaling in osteogenesis, and that Hh signaling
does not play an essential role in the late osteoblast differentiation
beyond an Osx-positive cell state.
BMP signaling has a positive impact on both osteogenesis and
chondrogenesis. Although the pathway is unlikely to be involved in
the speciﬁcation of the osteoblast linage, it has a positive effect, in
conjunctionwith Hh signaling, on osteoblast differentiation in vitro
and in vivo [82,83].We also recently reported that activation of BMP
signaling enhances ectopic chondrocyte formation in the peri-
chondrium in the absence of Hh input. Hh signaling suppresses
BMP-mediated chondrocyte differentiation in vitro [82]. Taken
together, these ﬁndings lead us to infer that among the osteo-
chondrogenic functions of BMP, osteogenic function is elicited by
Hh signaling in the perichondrium under physiological conditions.
3. Future perspective
Osteoblast differentiation is well coordinated by a number of
signaling pathways. In this context, the distinct window for each
signaling in terms of timing and the threshold level of its activation
is important. A major challenge for gaining a better understanding
of the ‘osteogenic signaling network’ is to reveal how these
signaling pathways are controlled to act within the proper window.Recently, Regard et al. identiﬁed Gas as a key regulator of proper
osteoblast differentiation maintaining a balance between the
Hedgehog and Wnt/b-catenin pathways [84].
It will also be beneﬁcial to identify the molecular mechanisms
underlying ligand secretion and diffusion to form the proper gra-
dients for functional outcomes. Another challenge is to identify the
gene regulatory network programming the osteoblast lineage.
Chromatin immunoprecipitation followed by massively-parallel
sequencing (i.e., ChIP-seq) is a powerful tool to extensively detect
protein-DNA binding events and histone modiﬁcations that high-
light the epigenetic state of the genome [85]. This approach may
provide insights into the regulatory networks in the osteoblast
lineage in terms of the target genes of transcription factors and the
stage-speciﬁc epigenetic landscape.
As described in this review, many signaling factors have already
been identiﬁed as osteogenic factors and some of them are thought
to be good candidates for skeletal tissue engineering. In order to
apply these factors to clinical settings, it will be important to
optimize the signaling activity for the target cells by integration of
the results of studies of drug delivery systems and scaffolds.
Conﬂict of interest
All authors declare no conﬂict of interest.References
[1] Kronenberg HM. Developmental regulation of the growth plate. Nature
2003;423(6937):332e6.
[2] Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B. The
transcription factor Sox9 has essential roles in successive steps of the chon-
drocyte differentiation pathway and is required for expression of Sox5 and
Sox6. Genes Dev 2002;16(21):2813e28.
[3] Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B. Sox9 is required for
cartilage formation. Nat Genet 1999;22(1):85e9.
[4] Colnot C, Lu C, Hu D, Helms JA. Distinguishing the contributions of the peri-
chondrium, cartilage, and vascular endothelium to skeletal development. Dev
Biol 2004;269(1):55e69.
[5] Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, et al. Targeted
disruption of Cbfa1 results in a complete lack of bone formation owing to
maturational arrest of osteoblasts. Cell 1997;89(5):755e64.
[6] Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, et al.
Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for
osteoblast differentiation and bone development. Cell 1997;89(5):765e71.
[7] Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, et al. The
novel zinc ﬁnger-containing transcription factor osterix is required for oste-
oblast differentiation and bone formation. Cell 2002;108(1):17e29.
[8] Akiyama H, Kim JE, Nakashima K, Balmes G, Iwai N, Deng JM, et al. Osteo-
chondroprogenitor cells are derived from Sox9 expressing precursors. Proc
Natl Acad Sci U S A 2005;102(41):14665e70.
[9] Rodda SJ, McMahon AP. Distinct roles for Hedgehog and canonical Wnt
signaling in speciﬁcation, differentiation and maintenance of osteoblast pro-
genitors. Development 2006;133(16):3231e44.
[10] St-Jacques B, Hammerschmidt M, McMahon AP. Indian hedgehog signaling
regulates proliferation and differentiation of chondrocytes and is essential for
bone formation. Genes Dev 1999;13(16):2072e86.
[11] Long F, Chung UI, Ohba S, McMahon J, Kronenberg HM, McMahon AP. Ihh
signaling is directly required for the osteoblast lineage in the endochondral
skeleton. Development 2004;131(6):1309e18.
[12] Mak KK, Chen MH, Day TF, Chuang PT, Yang Y. Wnt/beta-catenin signaling
interacts differentially with Ihh signaling in controlling endochondral bone
and synovial joint formation. Development 2006;133(18):3695e707.
[13] Ingham PW, McMahon AP. Hedgehog signaling in animal development: par-
adigms and principles. Genes Dev 2001;15(23):3059e87.
[14] Koziel L, Wuelling M, Schneider S, Vortkamp A. Gli3 acts as a repressor
downstream of Ihh in regulating two distinct steps of chondrocyte differen-
tiation. Development 2005;132(23):5249e60.
[15] Hilton MJ, Tu X, Cook J, Hu H, Long F. Ihh controls cartilage development by
antagonizing Gli3, but requires additional effectors to regulate osteoblast and
vascular development. Development 2005;132(19):4339e51.
[16] Joeng KS, Long F. The Gli2 transcriptional activator is a crucial effector for Ihh
signaling in osteoblast development and cartilage vascularization. Develop-
ment 2009;136(24):4177e85.
[17] Hojo H, Ohba S, Yano F, Saito T, Ikeda T, Nakajima K, et al. Gli1 protein par-
ticipates in Hedgehog-mediated speciﬁcation of osteoblast lineage during
endochondral ossiﬁcation. J Biol Chem 2012;287(21):17860e9.
H. Hojo et al. / Regenerative Therapy 1 (2015) 57e62 61[18] Ohba S, Kawaguchi H, Kugimiya F, Ogasawara T, Kawamura N, Saito T, et al.
Patched1 haploinsufﬁciency increases adult bone mass and modulates Gli3
repressor activity. Dev Cell 2008;14(5):689e99.
[19] Mak KK, Bi Y, Wan C, Chuang PT, Clemens T, Young M, et al. Hedgehog
signaling in mature osteoblasts regulates bone formation and resorption by
controlling PTHrP and RANKL expression. Dev Cell 2008;14(5):674e88.
[20] Maeda Y, Nakamura E, Nguyen MT, Suva LJ, Swain FL, Razzaque MS, et al.
Indian Hedgehog produced by postnatal chondrocytes is essential for main-
taining a growth plate and trabecular bone. Proc Natl Acad Sci U S A
2007;104(15):6382e7.
[21] Kimura H, Ng JM, Curran T. Transient inhibition of the Hedgehog pathway in
young mice causes permanent defects in bone structure. Cancer Cell
2008;13(3):249e60.
[22] Joeng KS, Long F. Constitutive activation of Gli2 impairs bone formation in
postnatal growing mice. PLoS One 2013;8(1):e55134.
[23] Andrade AC, Nilsson O, Barnes KM, Baron J. Wnt gene expression in the post-
natal growth plate: regulation with chondrocyte differentiation. Bone
2007;40(5):1361e9.
[24] Huelsken J, Birchmeier W. New aspects of Wnt signaling pathways in higher
vertebrates. Curr Opin Genet Dev 2001;11(5):547e53.
[25] Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev
Cell Dev Biol 1998;14:59e88.
[26] Mao J, Wang J, Liu B, Pan W, Farr 3rd GH, Flynn C, et al. Low-density lipo-
protein receptor-related protein-5 binds to Axin and regulates the canonical
Wnt signaling pathway. Mol Cell 2001;7(4):801e9.
[27] Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC. An LDL-receptor-
related protein mediates Wnt signalling in mice. Nature 2000;407(6803):
535e8.
[28] Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y, et al. LDL-re-
ceptor-related proteins in Wnt signal transduction. Nature 2000;407(6803):
530e5.
[29] Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C. Dickkopf-1
is a member of a new family of secreted proteins and functions in head in-
duction. Nature 1998;391(6665):357e62.
[30] Chamorro MN, Schwartz DR, Vonica A, Brivanlou AH, Cho KR, Varmus HE. FGF-
20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is
implicated in cancer and development. EMBO J 2005;24(1):73e84.
[31] Niida A, Hiroko T, Kasai M, Furukawa Y, Nakamura Y, Suzuki Y, et al. DKK1, a
negative regulator of Wnt signaling, is a target of the beta-catenin/TCF
pathway. Oncogene 2004;23(52):8520e6.
[32] Baﬁco A, Liu G, Yaniv A, Gazit A, Aaronson SA. Novel mechanism of Wnt
signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow.
Nat Cell Biol 2001;3(7):683e6.
[33] Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A, et al. LDL-receptor-related
protein 6 is a receptor for Dickkopf proteins. Nature 2001;411(6835):321e5.
[34] Semenov MV, Tamai K, Brott BK, Kuhl M, Sokol S, He X. Head inducer
Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 2001;11(12):
951e61.
[35] Johnson ML, Rajamannan N. Diseases of Wnt signaling. Rev Endocr Metab
Disord 2006;7(1e2):41e9.
[36] Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C. Canonical Wnt/
beta-catenin signaling prevents osteoblasts from differentiating into chon-
drocytes. Dev Cell 2005;8(5):727e38.
[37] Day TF, Guo X, Garrett-Beal L, Yang Y. Wnt/beta-catenin signaling in mesen-
chymal progenitors controls osteoblast and chondrocyte differentiation dur-
ing vertebrate skeletogenesis. Dev Cell 2005;8(5):739e50.
[38] Hu H, Hilton MJ, Tu X, Yu K, Ornitz DM, Long F. Sequential roles of Hedgehog
and Wnt signaling in osteoblast development. Development 2005;132(1):
49e60.
[39] Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, et al. LDL
receptor-related protein 5 (LRP5) affects bone accrual and eye development.
Cell 2001;107(4):513e23.
[40] Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, et al. High bone
density due to a mutation in LDL-receptor-related protein 5. N Engl J Med
2002;346(20):1513e21.
[41] Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass 2nd DA, et al. Cbfa1-
independent decrease in osteoblast proliferation, osteopenia, and persistent
embryonic eye vascularization in mice deﬁcient in Lrp5, a Wnt coreceptor.
J Cell Biol 2002;157(2):303e14.
[42] Bennett CN, Longo KA, Wright WS, Suva LJ, Lane TF, Hankenson KD, et al.
Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad
Sci U S A 2005;102(9):3324e9.
[43] Holmen SL, Giambernardi TA, Zylstra CR, Buckner-Berghuis BD, Resau JH,
Hess JF, et al. Decreased BMD and limb deformities in mice carrying mutations
in both Lrp5 and Lrp6. J Bone Miner Res 2004;19(12):2033e40.
[44] Bodine PV, Zhao W, Kharode YP, Bex FJ, Lambert AJ, Goad MB, et al. The Wnt
antagonist secreted frizzled-related protein-1 is a negative regulator of
trabecular bone formation in adult mice. Mol Endocrinol 2004;18(5):
1222e37.
[45] Tu X, Joeng KS, Nakayama KI, Nakayama K, Rajagopal J, Carroll TJ, et al.
Noncanonical Wnt signaling through G protein-linked PKCdelta activation
promotes bone formation. Dev Cell 2007;12(1):113e27.
[46] Takada I, Mihara M, Suzawa M, Ohtake F, Kobayashi S, Igarashi M, et al.
A histone lysine methyltransferase activated by non-canonical Wnt signalling
suppresses PPAR-gamma transactivation. Nat Cell Biol 2007;9(11):1273e85.[47] Schroeter EH, Kisslinger JA, Kopan R. Notch-1 signalling requires ligand-
induced proteolytic release of intracellular domain. Nature 1998;393(6683):
382e6.
[48] Honjo T. The shortest path from the surface to the nucleus: RBP-J kappa/Su(H)
transcription factor. Genes Cells 1996;1(1):1e9.
[49] Kopan R, Goate A. A common enzyme connects notch signaling and Alz-
heimer's disease. Genes Dev 2000;14(22):2799e806.
[50] Donoviel DB, Hadjantonakis AK, Ikeda M, Zheng H, Hyslop PS, Bernstein A.
Mice lacking both presenilin genes exhibit early embryonic patterning de-
fects. Genes Dev 1999;13(21):2801e10.
[51] Herreman A, Hartmann D, Annaert W, Saftig P, Craessaerts K, Serneels L, et al.
Presenilin 2 deﬁciency causes a mild pulmonary phenotype and no changes in
amyloid precursor protein processing but enhances the embryonic lethal
phenotype of presenilin 1 deﬁciency. Proc Natl Acad Sci U S A 1999;96(21):
11872e7.
[52] Engin F, Yao Z, Yang T, Zhou G, Bertin T, Jiang MM, et al. Dimorphic effects of
notch signaling in bone homeostasis. Nat Med 2008;14(3):299e305.
[53] Zanotti S, Smerdel-Ramoya A, Stadmeyer L, Durant D, Radtke F, Canalis E.
Notch inhibits osteoblast differentiation and causes osteopenia. Endocri-
nology 2008;149(8):3890e9.
[54] Hilton MJ, Tu X, Wu X, Bai S, Zhao H, Kobayashi T, et al. Notch signaling
maintains bone marrow mesenchymal progenitors by suppressing osteoblast
differentiation. Nat Med 2008;14(3):306e14.
[55] Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998;67:
753e91.
[56] Pogue R, Lyons K. BMP signaling in the cartilage growth plate. Curr Top Dev
Biol 2006;76:1e48.
[57] Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in
TGF-beta family signalling. Nature 2003;425(6958):577e84.
[58] Massague J, Seoane J, Wotton D. Smad transcription factors. Genes Dev
2005;19(23):2783e810.
[59] Pathi S, Rutenberg JB, JohnsonRL, VortkampA. Interactionof Ihh andBMP/Noggin
signaling during cartilage differentiation. Dev Biol 1999;209(2):239e53.
[60] Zou H, Wieser R, Massague J, Niswander L. Distinct roles of type I bone
morphogenetic protein receptors in the formation and differentiation of
cartilage. Genes Dev 1997;11(17):2191e203.
[61] Daluiski A, Engstrand T, Bahamonde ME, Gamer LW, Agius E, Stevenson SL,
et al. Bone morphogenetic protein-3 is a negative regulator of bone density.
Nat Genet 2001;27(1):84e8.
[62] Haaijman A, Burger EH, Goei SW, Nelles L, ten Dijke P, Huylebroeck D, et al.
Correlation between ALK-6 (BMPR-IB) distribution and responsiveness to
osteogenic protein-1 (BMP-7) in embryonic mouse bone rudiments. Growth
Factors 2000;17(3):177e92.
[63] Lyons KM, Pelton RW, Hogan BL. Organogenesis and pattern formation in the
mouse: RNA distribution patterns suggest a role for bone morphogenetic
protein-2A (BMP-2A). Development 1990;109(4):833e44.
[64] Minina E, Wenzel HM, Kreschel C, Karp S, Gafﬁeld W, McMahon AP, et al. BMP
and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and
differentiation. Development 2001;128(22):4523e34.
[65] Sakou T, Onishi T, Yamamoto T, Nagamine T, Sampath T, Ten Dijke P. Locali-
zation of Smads, the TGF-beta family intracellular signaling components
during endochondral ossiﬁcation. J Bone Miner Res 1999;14(7):1145e52.
[66] Yi SE, LaPolt PS, Yoon BS, Chen JY, Lu JK, Lyons KM. The type I BMP receptor
BmprIB is essential for female reproductive function. Proc Natl Acad Sci U S A
2001;98(14):7994e9.
[67] Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, et al.
Novel regulators of bone formation: molecular clones and activities. Science
1988;242(4885):1528e34.
[68] Gazzerro E, Canalis E. Bone morphogenetic proteins and their antagonists. Rev
Endocr Metab Disord 2006;7(1e2):51e65.
[69] Kaplan FS, Chakkalakal SA, Shore EM. Fibrodysplasia ossiﬁcans progressiva:
mechanisms and models of skeletal metamorphosis. Dis Model Mech
2012;5(6):756e62.
[70] Yoon BS, Ovchinnikov DA, Yoshii I, Mishina Y, Behringer RR, Lyons KM.
Bmpr1a and Bmpr1b have overlapping functions and are essential for chon-
drogenesis in vivo. Proc Natl Acad Sci U S A 2005;102(14):5062e7.
[71] Bandyopadhyay A, Tsuji K, Cox K, Harfe BD, Rosen V, Tabin CJ. Genetic analysis
of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis.
PLoS Genet 2006;2(12):e216.
[72] Kugimiya F, Kawaguchi H, Kamekura S, Chikuda H, Ohba S, Yano F, et al.
Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6
in bone formation. J Biol Chem 2005;280(42):35704e12.
[73] Okamoto M, Murai J, Yoshikawa H, Tsumaki N. Bone morphogenetic proteins
in bone stimulate osteoclasts and osteoblasts during bone development.
J Bone Miner Res 2006;21(7):1022e33.
[74] Mishina Y, Starbuck MW, Gentile MA, Fukuda T, Kasparcova V, Seedor JG, et al.
Bone morphogenetic protein type IA receptor signaling regulates postnatal
osteoblast function and bone remodeling. J Biol Chem 2004;279(26):27560e6.
[75] Kamiya N, Ye L, Kobayashi T, Lucas DJ, Mochida Y, Yamauchi M, et al.
Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA)
increases bone mass. J Bone Miner Res 2008;23(12):2007e17.
[76] Ellingsworth LR, Brennan JE, Fok K, Rosen DM, Bentz H, Piez KA, et al. Anti-
bodies to the N-terminal portion of cartilage-inducing factor A and trans-
forming growth factor beta. Immunohistochemical localization and
association with differentiating cells. J Biol Chem 1986;261(26):12362e7.
H. Hojo et al. / Regenerative Therapy 1 (2015) 57e6262[77] Morales TI, Joyce ME, Sobel ME, Danielpour D, Roberts AB. Transforming
growth factor-beta in calf articular cartilage organ cultures: synthesis and
distribution. Arch Biochem Biophys 1991;288(2):397e405.
[78] Matsunobu T, Torigoe K, Ishikawa M, de Vega S, Kulkarni AB, Iwamoto Y, et al.
Critical roles of the TGF-beta type I receptor ALK5 in perichondrial formation
and function, cartilage integrity, and osteoblast differentiation during growth
plate development. Dev Biol 2009;332(2):325e38.
[79] Seo HS, Serra R. Deletion of Tgfbr2 in Prx1-cre expressing mesenchyme results
in defects in development of the long bones and joints. Dev Biol 2007;310(2):
304e16.
[80] Tang Y, Wu X, Lei W, Pang L, Wan C, Shi Z, et al. TGF-beta1-induced migration
of bone mesenchymal stem cells couples bone resorption with formation. Nat
Med 2009;15(7):757e65.[81] Tu X, Joeng KS, Long F. Indian hedgehog requires additional effectors besides
Runx2 to induce osteoblast differentiation. Dev Biol 2012;362(1):76e82.
[82] Hojo H, Ohba S, Taniguchi K, Shirai M, Yano F, Saito T, et al. Hedgehog-Gli acti-
vators direct osteo-chondrogenic function of bone morphogenetic protein to-
ward osteogenesis in the perichondrium. J Biol Chem 2013;288(14):9924e32.
[83] Nakamura T, Aikawa T, Iwamoto-Enomoto M, Iwamoto M, Higuchi Y,
Paciﬁci M, et al. Induction of osteogenic differentiation by hedgehog proteins.
Biochem Biophys Res Commun 1997;237(2):465e9.
[84] Regard JB, Malhotra D, Gvozdenovic-Jeremic J, Josey M, Chen M, Weinstein LS,
et al. Activation of Hedgehog signaling by loss of GNAS causes heterotopic
ossiﬁcation. Nat Med 2013;19(11):1505e12.
[85] MacQuarrie KL, Fong AP, Morse RH, Tapscott SJ. Genome-wide transcription
factor binding: beyond direct target regulation. Trends Genet 2011;27(4):141e8.
